FSB Premier Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$288K Sell
2,238
-50
-2% -$5.85K 0.08% 209
2026
Q1
$275K Buy
2,288
+382
+20% +$44.1K 0.09% 214
2025
Q4
$201K Sell
1,906
-477
-20% -$44.8K 0.06% 235
2025
Q3
$200K Buy
+2,383
New +$196K 0.07% 227
2025
Q2
– Sell
-2,340
Closed -$210K – 216
2025
Q1
$210K Buy
2,340
+57
+2% +$5.32K 0.08% 198
2024
Q4
$227K Buy
2,283
+125
+6% +$12.9K 0.09% 196
2024
Q3
$245K Buy
2,158
+126
+6% +$15K 0.1% 182
2024
Q2
$252K Hold
2,032
– – 0.11% 162
2024
Q1
$268K Hold
2,032
– – 0.12% 150
2023
Q4
$222K Hold
2,032
– – 0.11% 159
2023
Q3
$209K Buy
2,032
+18
+0.9% +$1.94K 0.12% 151
2023
Q2
$232K Buy
+2,014
New +$229K 0.13% 137
2022
Q1
– Sell
-2,117
Closed -$162K – 370
2021
Q4
$162K Buy
+2,117
New +$169K 0.07% 138

Other funds holding MRK

FSB Premier Wealth Management's MRK Position: Q2 2026 in Review

FSB Premier Wealth Management reduced its Merck (MRK) stake by 2.2% in Q2 2026, selling an estimated $5.85K and leaving 2,238 shares worth $288K. The position accounts for 0.08% of the portfolio, ranked #209.

FSB Premier Wealth Management first reported a position in MRK in Q4 2021 and has held it in 13 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • FSB Premier Wealth Management held 2,238 shares of Merck worth $288K as of Q2 2026.
  • FSB Premier Wealth Management sold 50 Merck shares in Q2 2026, an estimated $5.85K.
  • Merck made up 0.08% of FSB Premier Wealth Management's portfolio in Q2 2026, its #209 holding.
  • FSB Premier Wealth Management first reported a position in Merck in Q4 2021 and has held it in 13 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on FSB Premier Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.